Exelixis Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| MRK | Merck | Outperform |
2
|
$131.19 | Buy/Sell | $130.51 | 9.00% | 11 | $332.28B |
| ROG | Roche Holding | Hold |
16
|
CHF237.10 | Buy/Sell | CHF307.83 | 14.93% | 9 | CHF191.28B |
| PFE | Pfizer | Outperform |
2
|
$28.64 | Buy/Sell | $32.87 | 6.49% | 6 | $162.29B |
| REGN | Regeneron Pharmaceuticals | Outperform |
2
|
$982.29 | Buy/Sell | $961.26 | 6.89% | 8 | $105.97B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$44.03 | Buy/Sell | $58.15 | 22.64% | 10 | $89.25B |
| BAYN | Bayer | Hold |
5
|
28.58€ | Buy/Sell | 45.15€ | 4.97% | 4 | 28.08€B |
| 4523 | Eisai | Outperform |
18
|
¥6.78k | Buy/Sell | ¥9.58k | 23.91% | 0 | ¥1.97T |
| INCY | Incyte | Outperform |
9
|
$57.10 | Buy/Sell | $77.05 | 37.48% | 8 | $12.01B |
| JAZZ | Jazz Pharmaceuticals | Outperform |
14
|
$108.99 | Buy/Sell | $188.32 | 72.49% | 4 | $7.13B |
| BPMC | Blueprint Medicines | Outperform |
6
|
$104.96 | Buy/Sell | $85.71 | 14.33% | 5 | $6.78B |
| IONS | Ionis Pharmaceuticals | Outperform |
9
|
$37.31 | Buy/Sell | $55.60 | 60.81% | 3 | $5.76B |